Sort   by:  
 Page size 
ProteomicsCharacterization of Chemotherapy-treated PyMT Liver Matrisome
Metastasis accounts for 90% of cancer-related deaths, yet the mechanisms by which cancer cells colonize secondary organs remain poorly understood. For breast cancer patients, metastasis to the liver is associated with poor prognosis and a median survival of 6 months. Standard of care is chemotherapy...
ORGANISM(S): Mus musculus (Mouse) 
2022-10-05 | PXD036736 | Pride
Breast cancer Mouse Liver metastasis 
ProteomicsCharacterization of the Chemotherapy-treated PyMT Matrisome
Cytotoxic chemotherapy is used to treat many thousands of patients across many cancer types annually. Recent studies have demonstrated that chemotherapy causes systemic response that can be exploited to promote cancer cell survival and dissemination, termed “chemotherapy-induced metastasis. However,...
ORGANISM(S): Mus musculus (Mouse) 
2022-03-14 | PXD032002 | Pride
Breast cancer Chemotherapy Extracellular matrix 
Sort   by:  
 Page size